Evaluation of the Antiviral Activity of Cuscuta Extracts Against HSV-1, HSV-2 (ACV-Resistant Strain), HCoV229E and SARS-CoV-2
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188120 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Zornitsa Tileva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology, Faculty of Biology, University of Sofia "St. Kliment Ohridski", 1164 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Plant Extracts, Antiviral Agents, Herpesvirus 2, Human, Herpesvirus 1, Human. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre of Competence "Sustainable Utilization of Bio-resources and Waste of Medicinal and Ar-omatic Plants for Innovative Bioactive Products" (BIORESOURCES BG), The Scientific Research Department (NIS) of Sofia University “St. Kliment Ohridski”.
Abstract (Originalsprache)
The toxicological risk and development of resistance associated with synthetic drugs and supplements can be reduced by focusing efforts on medicinal plants that are of interest in pharmacognostic research to find new drugs or templates for the development of new bioactive compounds. The parasitic plant Cuscuta spp. has significant pharmacological activity at the extract level, but there is limited data on the bioactivity of its chemical compounds. In the present study, we aimed to investigate the antiviral potential of extracts obtained from different parts of two species, C. campestris and C. epithymum. The two species clearly differ in their flavonoid profiles, which could also suggest different antiviral activities of the extracts. We used methanol and aqueous extracts, MDBK, VERO E6 clone 76 and BGM cell lines, HSV-1, HSV-2 strain DD (acyclovir-resistant), HCoV-229E and SARS-CoV-2, maximum tolerable concentration, the MTT test, the plaque-forming method and the HPLS-MS analysis. It was found that the metabolic composition varies depending on the host plant. We hypothesize that differences in the composition of the extracts lead to differences in antiviral activity. Some of the tested methanol extracts showed a pronounced inhibitory effect, both on replication and on extracellular virions, in relation to the ACV-resistant strain of HSV type 2 and SARS-CoV-2 in comparison with the other viral models used by us. The strongest antiviral effect was shown by the methanol extract of C. campestris with host Chenopodium spp. against SARS-CoV-2, as the virus inhibition was about 100%, and the virucidal effect showed a decrease in the viral titer by more than 2.5 lg. Based on the results obtained, we assume possible antagonistic interaction of individual metabolites in the total methanol extracts. Extract C3, applied at the maximum tolerable concentration and one level lower, inhibits SARS-CoV-2 about 100 percent. SARS-CoV-2-infected cells preserved mitochondrial activity and relatively preserved lysosomal activity; this is also the reason why the MTT test, as well as neutral red staining, is not applicable to this viral model propagated in the VERO E6 cell line.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Virology, Faculty of Biology, University of Sofia "St. Kliment Ohridski", 1164 Sofia, Bulgaria.
- Centre of Competence "Sustainable Utilization of Bio-Resources and Waste of Medicinal and Aromatic Plants for Innovative Bioactive Products" (BIORESOURCES BG), 1000 Sofia, Bulgaria.
- Department of Biochemistry, Faculty of Biology, Sofia University "St. Kliment Ohridski", 1164 Sofia, Bulgaria.
- Department of Medical Microbiology "Corr. Mem. Prof. Ivan Mitov, MD, DMSc", Faculty of Medicine, Medical University of Sofia, 1431 Sofia, Bulgaria.
ORCID-Profile: Petya Angelova, Stoyan Shishkov, Lyuben Zagorchev, Denitsa Teofanova, Ivo Sirakov
Förderung
- Centre of Competence "Sustainable Utilization of Bio-resources and Waste of Medicinal and Ar-omatic Plants for Innovative Bioactive Products" (BIORESOURCES BG)
- The Scientific Research Department (NIS) of Sofia University “St. Kliment Ohridski”
Zitieren
APA
Tileva, Z., Angelova, P., Hinkov, A., Shishkov, S., Zagorchev, L., Teofanova, D., Sirakov, I., & Shishkova, K. (2026). Evaluation of the Antiviral Activity of Cuscuta Extracts Against HSV-1, HSV-2 (ACV-Resistant Strain), HCoV229E and SARS-CoV-2. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188120
Vancouver
Tileva Z, Angelova P, Hinkov A, Shishkov S, Zagorchev L, Teofanova D, et al. Evaluation of the Antiviral Activity of Cuscuta Extracts Against HSV-1, HSV-2 (ACV-Resistant Strain), HCoV229E and SARS-CoV-2. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188120
BibTeX
@article{Tileva2026,
author = {Tileva, Zornitsa and Angelova, Petya and Hinkov, Anton and Shishkov, Stoyan and Zagorchev, Lyuben and Teofanova, Denitsa and Sirakov, Ivo and Shishkova, Kalina},
title = {Evaluation of the Antiviral Activity of Cuscuta Extracts Against HSV-1, HSV-2 (ACV-Resistant Strain), HCoV229E and SARS-CoV-2},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188120}
}
EUVIMED